Maximize your PD and manufacturing capabilities

Are you having challenges with data collection, remote equipment monitoring or digital connectivity? Do you think automation is only for commercial manufacturing? No matter what phase you are, automation can help you accelerate. This year, Cytiva introduced Chronicle - a software designed specifically to address challenges in cell therapy. Capable of eSOPs, batch release by exception, visibility of global manufacturing sites, data collection, and more, Chronicle grows with your output and opens new possibilities your current method of paper and pen or decentralized connectivity simply cannot. Join us for a presentation on how Chronicle is revolutionizing the advancements and scalability of cell therapy manufacturing.

Speakers:
George White, Product Strategy Manager, Cytiva
Per Hammer, Senior Global Product Manager, Cytiva

George has 15 years’ experience in the cell and gene therapy industry, predominantly in commercial roles supporting academic research through to industrial scale up and manufacture. George joined GE Healthcare’s Life Sciences business, now Cytiva, in 2013 and has been an actively involved in the integrations of the Biosafe and Asymptote businesses. George recently moved from his role as Commercial GM for EMEA, to Global Product Strategy Manager to further support the development products and services into the Cell and Gene Therapy space.

Per Hammer has a 19 years’ experience in the biopharma industry, mainly from automation and digital roles supporting customers in academics through process development and into manufacturing. Per joined GE Healthcare’s Life Sciences business in 2001 and have since then had several different roles in the company. Most recently Per moved from the position as Product Manager leader for the Bioprocess Automation and Digital team and is now Senior Product Manager for the Cell & Gene Therapy Automation and Digital solutions.